Vaccine Billionaires and Human Guinea Pigs
By Colin Todhunter | OffGuardian | July 3, 2021
How do you make a potentially dangerous and ineffective drug appear like a miracle of modern science? You could, for instance, enrol only certain people in clinical trials and exclude others or bring the study to a close as soon as you see a spike in the data that implies evidence of effectiveness.
There are many ways to do it.
According to health practitioner and writer Craig Stellpflug in his article ‘Big Pharma: Getting away with murder’(2012), the strategy is to get in quick, design the study to get the result you want, get out fast and make lots of money.
Stellpflug says:
If a study comes up negative for your favorite drug, just don’t publish it! 68 per cent of all drug studies are swept under the carpet to keep those pesky side effects from being reported. Only 32 per cent of studies come up positive and a lot of those studies are ‘shortened’ to limit the long-term findings. Studies cut short were found to overestimate the study drug’s effectiveness and miss dangerous side effects and complications by an average of 30 per cent. This would explain the amazing 85 per cent drug study success rate in the hands of Big Pharma according to the Annals of Internal Medicine.”
Of course, it helps to get the regulatory agencies on board and to convince the media and health officials of the need for your wonder product and its efficacy and safety. In the process, well-paid career scientists and ‘science’ effectively become shaped and led by corporate profit margins and political processes.
And what better way to make a financial killing than by making a mountain out of a molehill and calling it a ‘pandemic’?
COVID-19 VACCINE CONCERNS
The Wall Street Journal recently published an article by two health professors who said politics — not science — is behind the failure of health officials and the media to fully inform the public about the potential risks associated with COVID vaccines.
Although the article is available in full to subscribers only, the Children’s Health Defense (CHD) website provides an informative summary.
The CHD notes that Dr Joseph A Ladapo, associate professor of medicine at the David Geffen School of Medicine, and Dr Harvey A Risch, professor of epidemiology at Yale School of Public Health, wrote that while prominent scientists have raised concerns that the safety risks of Covid-19 vaccines have been underestimated, the politics of vaccination has relegated their concerns to the outskirts of scientific thinking.
The two professors noted that clinical studies do not always tell the full story about the safety of medications and that the health effects often remain unknown until the medicine is rolled out to the general public. Examples include Vioxx, a pain reliever that increased the risk of heart attack and stroke; antidepressants that appeared to increase suicide attempts among young adults; and an influenza vaccine used in the 2009-10 swine flu epidemic that was suspected of causing febrile convulsions and narcolepsy in children.
The authors added that clinical trials often enrol patients who are not representative of the general population and more is learnt about drug safety from real-world evidence. With this in mind, they said the large clustering of side effects following COVID vaccines is concerning as is the silence around these potential signals of harm.
Serious adverse events reported by the Vaccine Adverse Event Reporting System include low platelets, heart inflammation, deep-vein thrombosis and death. However, the two scientists argue this is likely to be a fraction of the total number of adverse events.
They criticise the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) for ignoring the reported serious COVID vaccine side effects.
The authors acknowledge the risks of COVID vaccines in certain populations, not least children, may outweigh the benefits. They also state that not a single published study has demonstrated that patients with a prior infection benefit from COVID-19 vaccination. Something which is not readily acknowledged by the CDC or Anthony Fauci, an indication, according to the authors, of how deeply entangled pandemic politics is in science.
They conclude that public health authorities are making a mistake and risking public erosion of trust by not being forthcoming about the possibility of harm from the vaccines.
MERCK AND VIOXX
It is revealing that the two scientists refer to Vioxx, which was once popular for treating the symptoms of arthritis. It was removed from the market in 2004 after concerns that it may have injured hundreds of thousands of patients, while possibly killing tens of thousands in the US.
Dr David Graham, whistleblower and senior FDA investigator, criticised the FDA’s approval process of Vioxx (rofecoxib), an anti-inflammatory drug administered orally. In various interviews and congressional hearings, he described the outcome of Vioxx as disastrous and unparalleled in the history of the US. He added that the saga surrounding Vioxx had constituted an unprecedented failure of the nation’s system of drug approval and oversight.
In 2004, Graham argued that the painkiller had caused 88,000 to 139,000 heart attacks in the US – 30-40 per cent of which were fatal – over the previous five years. Nevertheless, manufactured by Monsanto (a company with a proven track record of corrupt practices) and co-marketed by Merck, Vioxx became a leading drug in providing pain relief from the symptoms of various forms of arthritis.
Research presented to the FDA in early 2001 showed that patients taking Vioxx had a higher risk of heart attack compared to those taking some of the older alternatives.
However, the real game-changer came in 2004 when Dr Graham released the findings that found Vioxx increased the chance of heart attack and death from cardiac arrest significantly more than its biggest rival on the market. Dosages of Vioxx in excess of the recommended daily dose of 25 milligrams were also found to more than triple a patient’s risk compared to those who had not taken painkillers.
In September 2004, Vioxx was pulled from the market. But in 2006, more damning findings were revealed by a study that showed that some patients had likely suffered from a heart attack much sooner after starting treatment with Vioxx.
Appearing in the Canadian Medical Association Journal, the study showed that 25 per cent of the patients who had heart attacks while taking Vioxx did so within two weeks of starting the drug. This indicated that Vioxx-related cardiovascular risks may occur much earlier than previously thought.
The FDA was criticised for its close relationship with Merck and witnesses at a senate finance committee hearing described how danger signals of Vioxx went ignored. Indeed, a 2007 article published by the National Institutes of Health alleged that even though scientists at Merck knew that the drug might adversely affect the cardiovascular system, none of the intervention studies submitted to the FDA in 1998 were designed to evaluate such risk.
ROBBER BARONS AND GUINEA PIGS
Merck reported over $11 billion in Vioxx sales during the five years the drug was on the market. To date, the company has paid nearly $6 billion in litigation settlements and criminal fines over Vioxx. Still, in hard-nosed commercial terms, it was a massive success, resulting in a $5 billion gain for the company.
In May 2021, it was reported that Covid-19 vaccines had created at least nine new billionaires. According to research by the People’s Vaccine Alliance, the new billionaires included Moderna CEO Stéphane Bancel and Ugur Sahin, the CEO of BioNTech, which has produced a vaccine with Pfizer. Both CEOs were then worth around $4 billion. Senior executives from China’s CanSino Biologics and early investors in Moderna have also become billionaires.
Although the nine new billionaires are worth a combined $19.3 billion, the vaccines were largely funded by public money. For instance, according to a May 2021 report by CNN, BioNTech received €325 million from the German government for the development of the vaccine. The company made a net profit of €1.1 billion in the first three months of the year, largely thanks to its share of sales from the Covid-19 vaccine, compared with a loss of €53.4 million for the same period last year.
Moderna’s Covid-19 vaccine sales reached $1.7 billion in the first three months of this year and it had its first profitable quarter ever. Moderna is expected to make $13.2 billion in Covid-19 vaccine revenue in 2021. The company received billions of dollars in funding from the US government for development of its vaccine.
Big Pharma has every reason to perpetuate the notion of a deadly global pandemic and to inflate the efficacy of and need for its vaccines. And it, along with its associates in government and at the WHO, has every reason to discredit alternative and arguably more effective treatments like Ivermectin (see the online article ‘The Campaign against Ivermectin: WHO’s Chief Scientist Served with Legal Notice for Disinformation and Suppression of Evidence‘).
There is no need to cover ground here that has been covered extensively elsewhere but it is now abundantly clear that many continue to question the overall official COVID-19 narrative, the fear propaganda, the specific data, the PCR testing protocols, the apparent conflicts of interest and vaccine efficacy.
Moreover, A group of 57 leading scientists, doctors and policy experts recently released a report calling into question the safety and efficacy of the current Covid-19 vaccines. They are calling for an immediate end to all vaccine programmes.
There are hundreds of scientists who have questioned governmental and WHO strategy and who have brought attention to the extremely low risks posed by COVID to the bulk of the population as well as the destructive (ineffective) policies and decisions pertaining to lockdowns and other restrictions.
There are many other top scientists who are questioning the need for mass vaccination and who have also pointed out credible and extremely disturbing side effects (real and potential) of such a strategy, not least Dr Robert Malone, credited with developing mRNA vaccine technology, Dr Byram Bridle, a viral immunologist, and Dr Geert Vanden Bossche, a prominent virologist and vaccine expert.
Unlike Merck and Vioxx, it will be governments (the public) that foot any future indemnity costs of these experimental vaccines that have escaped proper (long-term) testing. And given the scale of the rollout, the damage caused could make the adverse effects of Vioxx seem a mere blip.
Vaccines that were brought to market via emergency authorisation use for an ‘emergency’ constructed on the basis of deaths so often wrongly attributed to COVID-19. Brought to market on the basis of flawed PCR test protocols with magnification cycles primed to create a ‘casedemic’.
To borrow from Dr David Graham: are we currently witnessing something more disastrous and unparalleled in the history of the world, let alone the US: an unprecedented failure of gobal drug approval and oversight?
In the meantime, while billions of vaccinated people serve as human guinea pigs, the newly crowned vaccine kings will make hay while the sun shines (and the fear continues).
Who Stole the People’s Money?
BY PHILIP GIRALDI • UNZ REVIEW • JUNE 29, 2021
Too many American politicians at all levels of government have come to believe that your money is their money. Federal, state and local tax rates are set annually and often arbitrarily based on the issues that elected officials and tax managers consider to be important. Input from the public is basically unwelcome except at election time but, even then, the breakdown of dollars and cents that will be coming out of one’s pocket is rarely under discussion.
It is past time to consider what the pie in the sky being proposed by the Democrats, since they are currently in power, will actually cost the American taxpayer. Bear in mind, that Democratic Party proposals that are now being floated are directed at certain constituencies that the party is seeking to weld into an unbeatable coalition that will defy all Republican attempts to recover either Congress or the Presidency. Similar activity is taking place at the state and local level. There is no consideration of the fact that government, at least theoretically, is intended to benefit all of the citizenry, not a select portion thereof that will henceforth be required to deliver the vote loyally. Politicians who manipulate the system with that in mind should be sent to jail, but alas, in the US system no one is ever punished, even if they start a war under false premises as did former President George W Bush and his apparatchiks.
Under the Democrats, the entire process whereby the spoils derived from being in power are distributed is being driven by social engineering, i.e. race and gender. One of President Joe Biden’s first moves upon taking office was to propose special payments and other incentives for black farmers, who, his administration argued, had been disadvantaged because they had been systematically denied loans for many years. It should seem outrageous that federal tax dollars were to be used to support only one racial group, but not a single Democrat appeared to be disturbed. Fortunately, a federal court ruled favorably in a case brought by a white farmer claiming that racially directed government assistance is unconstitutional as it violates the “equal protection under the law” principle. The Democrats are, however, continuing to push for their program of tying blacks firmly into their coalition, even if it means creating a system that is manifestly and even transparently unfair.
One of the most bizarre news stories of the past several weeks has to be the revelation that the Defense Department will be paying for transgender surgery for those biological males in the ranks that want to become women and vice versa. One can honestly accept that there are transgender individuals in the so-called armed services and they deserve respect for what they perhaps quite genuinely are, but this goes well beyond that. In the usual squeaky-voiced pander much favored by the Biden Administration, Veteran Affairs Secretary Denis McDonough announced during “Pride Week” that the new guidelines would create a “safe and caring” environment for all veterans, while also citing the “dark history” of discrimination against gay and transgender military personnel. “Safe and caring?” Our military? Hope they never have to fight a real war.
The White House also got into the promotion, releasing a statement that “President Biden believes that gender identity should not be a bar to military service and that America’s strength is found in its diversity. This question of how to enable all qualified Americans to serve in the military is easily answered by recognizing our core values. America is stronger, at home and around the world, when it is inclusive. The military is no exception. Allowing all qualified Americans to serve their country in uniform is better for the military and better for the country because an inclusive force is a more effective force. Simply put, it’s the right thing to do and is in our national interest.”
The statement is, like many Executive Order signing statements coming out of the Biden White House, complete nonsense. The historically most effective fighting forces have had high levels of cohesion, not diversity and it is difficult to imagine what the national interest would be in having an army that can’t fight. Transgenders were, in fact, first allowed to serve, predictably, under President Barack Obama before being blocked by President Donald Trump. They are now again a cherished part of the military community under Honest Joe Biden and both active duty transgenders and veterans will soon be able to receive gender-transition surgeries, mostly through the Veterans Affairs (VA) health care coverage. It is estimated that there are now 15,000 transgender individuals on active duty while possibly as many as 135,000 more are veterans. The numbers seem impossibly large, but gender transition surgeries will now be covered by the string of military hospitals and the veteran healthcare network.
Bear in mind that transgender transformation surgery is not urgent care or even health maintenance: it is an optional procedure intended to turn G.I. Joe into G.I. Jane or the reverse. Also bear in mind that the US taxpayer submits to the burden of the enormous and growing so-called Defense budget in the belief that it exists to protect the United States, not to change genders of American citizens who might be enlisting in the military precisely to obtain that benefit. According to a recent estimate the cost of the procedure can range from $15,000 up to more than $50,000 depending on how extensive the surgery is. Multiply that by 150,000 to get some idea of what the pander to gender obsessed fanatics in the Democratic Party and among its limousine liberals base will cost the average taxpayer, who will get nothing in return from it.
The Pentagon, of course, is fully engaged in the war on extremism and is also actively promoting the racist Critical Race Theory while rooting out extremists, which means white people, who are evil supremacists both genetically and by definition. CRT is, by the way, a remarkable Marxist-based invention that blames most bad things in America on white people. And it is being forced on the public by the usual zealots with the claim that it will make everyone the beneficiary of “equity.” On the contrary it makes Americans less well educated and dependent on government for handouts.
Even counties and school districts that have had no racial issues are being forced to hire Diversity & Equity Managers and high-priced consultants to explain the new reality. As a manifestation of CRT thinking, Fred Reed observes how increasingly in American schools “Math curricula are being dumbed down because blacks do poorly at math, English grammar instruction eliminated because blacks can’t or won’t learn it, entrance exams for the elite and demanding high schools eliminated because blacks don’t pass them, SATs dropped because blacks score poorly on them, promotion exams in police departments eliminated because blacks don’t pass them. Entrance requirements at medical school are lowered because not enough blacks pass them, AP courses in high school eliminated because too few blacks get into them… White parents are forced to see their children subjected to what they regard as obscene, semiliterate, violent, stupid, a culture dominated by what seems to them, (and would to any First World country) the opposite of cultivation.”
And, to be sure, the military is leading the way to join the new world order. Seeking to promote both racial and gender diversity in its ranks, the Navy has created a task force designed to “combat discrimination,” which inter alia requires sailors to take a pledge to “acknowledge all lived experiences and intersectional identities,” whatever that is supposed to mean. The Army is also doing its bit. In a recent appearance before Congress Joint Chiefs of Staff Chairman General Mark Milley “defended the teaching of critical race theory at West Point and, referencing the January 6 Capitol riot, said, ‘it is important that we train and we understand … and I want to understand white rage. And I’m white.’”
Milley, who seems unaware of the “black rage” that has been burning, looting and shooting over the past year, particularly stressed the impact of the January 6th Capitol Building “insurrection,” saying “What is it that caused thousands of people to assault this building and try to overturn the Constitution of the United States of America? What caused that?”
It is important to seek to understand what Milley has bought into: putting the military squarely on the side of the administration in the cultural wars currently being endured while making clear who the enemy is: white America. Some cynics observed that Milley and the military-industrial-complex behind him, who collectively speaking cannot any longer fight and win a war, are chiefly concerned with the hundreds of billions of dollars that they enjoy annually. To secure that it is necessary to play nice with whatever the White House, and the woke media, are peddling. Again, it all comes down to money that is stolen from taxpayers in this country. Time for the taxpayers themselves to put an end to the nonsense.
Philip M. Giraldi, Ph.D., is a veteran of the US Army and a former Central Intelligence Agency Case Officer.
American Medicine, American Malfeasance
By Dr. Gary Null and Richard Gale | Global Research | June 26, 2021
An issue that is rarely discussed or given serious attention is the over-specialization in healthcare. Modern medicine’s approach to identify and treat illnesses and tackle the reduction of infections has in many instances ceased to be multidisciplinary. Medicine has also become increasingly compartmentalized and confined to a rigid materialistic belief system that has now established its own set of standards, criteria and values that are often contrary to gold-standard scientific protocols. The consequence is that its narrow single-mindedness has insulated modern medicine from objective criticism and preserved its internal flaws, errors and fabrications, which have contributed to the unnecessary injury and death of countless patients.
US healthcare spending reached $3.8 trillion in 2019. Due to the Covid pandemic, expenditures for 2020 will be astronomically higher. One might expect that with the world’s most expensive healthcare system, the US would equally have the best evidence-based practices to keep its citizens healthy. By now we should be proficiently expert at preventing and reversing disease, while making minimal errors resulting in injury or death. However, the exact opposite is the case. Instead of minimizing disease-causing factors, American medicine causes more illness through misguided diagnostic testing, overuse of medical and surgical procedures, and over prescribing pharmaceutical drugs. The fundamental reason for this catastrophe is that today’s healthcare establishment, and corporate science in general, over relies on profit-generating motives.
Dr. Peter Gotzsche is arguably recognized as one of the world’s foremost experts in evaluating evidence-based medicine (EBM). As the co-founder of EBM’s preeminent flagship organization – the Cochrane Collaboration — to review and analyze peer-reviewed clinical research, he is intimately knowledgeable about the widespread corruption permeating the pharmaceutical industry and medical journals. In his book Deadly Medicines and Organized Crime, he writes,
“The reason why we take so many drugs is that drug companies do not sell drugs. They sell lies about drugs… The patients do not realize that although their doctors know a lot about diseases, human physiology and psychology, they know very little about the drugs that have been concocted and dressed up by the drug industry.”
After we take a fair and objective look at American medicine during the past five decades, especially at the statistics of iatrogenic fatalities, or deaths caused by prescribed medications and medical error, our healthcare establishment is found to be anything but benign. Despite its many noteworthy discoveries and merits, a substantial amount of recommended medical practice has failed patients. “If the medical system were a bank,” writes Dr. Stephen Persell at Northwestern University’s School of Medicine, “you wouldn’t deposit your money here, because there would be an error every one-in-two to one-in-three times you made a transaction.” Dr. Persell is referring to the rates of preventable medical errors causing patients serious injury and now the third leading cause of death.
There is excellent evidence to support the argument that iatrogenic deaths have passed cancer fatalities and are now challenging heart disease for the number one spot. A 2008 study found as many as half of adverse events reported by patients were not recorded in their hospital charts. As of 2017, investigations continue to find that less than 10% of medical errors are reported. Reported adverse effects vary depending on the specialty and frequently go unnoticed or are improperly evaluated. An additional study found that almost two thirds of cardiologists had refused to report a serious error they had direct personal knowledge of to an authority.
As one example, heart disease is America’s leading cause of fatality, accounting for 665,000 deaths annually. The CDC, which consistently undermines health threats if it means positioning itself in opposition to private commercial interests, estimates that 34 percent of cardiovascular fatalities are premature and preventable. In contrast, the American Heart Association claims 80 percent are preventable. What are the heads of our federal health agencies doing to advocate on the side of prevention? Little to nothing.
There is no realistic and science-based national policy in place to lessen cardiovascular, cancer and diabetic death rates. Since the most viable and effective means to prevent these diseases are natural and within every person’s means, it is not financially lucrative to divert federal funding away from pharmaceutical treatments and surgical procedures. The CDC and FDA are largely dependent upon monetary income received from the drug and medical device industries.
Earlier we reported about the systemic corruption and fraud that has plagued the CDC and FDA for decades. It would be far cheaper to completely empty, dismantle, fumigate and rebuild the agencies anew rather than continue exerting pressure for reforms, which have only perpetuated a killing spree by protecting life-threatening drugs, vaccines and unnecessary medical procedures. Dr. Gotzsche notes, the same is true for private drug companies. Despite the numerous lawsuits drug companies have lost in federal courts, nothing has fundamentally changed in order to deter them from illegal activities to increase profits. In fact, the cost of paying out settlements and settling lawsuits is factored into the expense of doing business.
A decade ago, we teamed up with three board-certified physicians to undertake the task to review the peer-reviewed literature in order to recalculate the statistics from many branches of medicine in order to arrive at a more realistic casualty rate due to medical error. We began with a basic question. Do the current standards of American medical practice and its supporting science prove that the recommended therapies and healthcare protocols – whether drugs, surgery, diagnostic methods, medical devices, etc – are actually effective? And if so, at what cost to the patients’ health and well-being?
Our results and final conclusions were startling and culminated in the release of a widely read and referenced book, Death by Medicine. We made every effort to avoid editorial commentary to our findings. We decided to only report the statistics and facts with our calculations. The fact that our data placed iatrogenic error as the number one cause of death in America was alone sufficient. What was novel in our analysis was that we included preventable deaths, such as certain infections and severe nutrient deficiency, which could have been easily corrected by clinicians and medical personnel if viable prevention programs had been part of our healthcare system. After publication the book was sent to hundreds of journalists, federal officials and non-profit medical organizations. It was completely ignored by the orthodoxy; however, it became increasingly popular among alternative and complementary medical physicians who were already fully aware of the structural dangers to public health within conventional medical care.
Revisiting American medicine’s legacy of iatrogenic deaths is now more crucial than ever because the same behaviors that have contributed to the nation’s leading cause of death are being repeated during the Covid-19 pandemic. The government and federal health officials are in reprehensible denial of inexpensive and highly effective drugs, such as Ivermectin and hydroxychloroquine, to treat early and middle stage SARS-2 infections. Cases of Covid infections and deaths have been grossly exaggerated. And now we are realizing that the efficacy and safety profiles of the vaccines are orchestrated scams. As a result, the entire institutional edifice to vaccinate the global population is destined to become the greatest scandal of the 21st century.
Unfortunately, nobody can acquire accurate statistics for Covid-19 vaccine associated injuries and deaths from the CDC’s Vaccine Adverse Events Reporting System (VAERS). Careful weekly monitoring of VAERS’ adverse event updates convince us that the entire system is criminally rigged. CDC officials overseeing the database are undoubtedly fudging numbers after ratio of adverse events, including deaths, per number of doses administered are compared to the more robust and accurate EudraVigilance database in the European Union and the less reliable Yellow Card System in the UK.
As of June 17, VAERS was reporting 329,021 injuries and 5,888 deaths due to the Covid vaccines. The database’s most recent update is reporting an additional 26,541 injuries but 1,972 less deaths. How can this sudden disappearance of almost 2,000 deaths be accounted for? The mysterious loss of fatality entries occurred during the same week as a CDC working group of outside medical professionals was reviewing an association between the mRNA vaccines and the rising number of reported cases of cardiac inflammation or myocarditis. The group concluded that there is indeed “a likely association.” The occasion of deleted deaths in VAERS is also on the heels of the Israeli Shamir Medical Center report that Pfizer’s vaccine is linked with occurrences of thrombotic thrombocytopenic purpura, an autoimmune disorder associated with a rare form of blood clotting. However, despite weekly local news stories around the nation about youth as young as 19 years of age dying of vaccine complications shortly after receipt of an mRNA vaccine, the CDC is claiming that all 1,200 persons, between 16-24 years of age, recovered and no deaths were reported. Does this account for the likely scrubbing of entries in VAERS?
But it is much worse. We only need to look at the European Union’s statistics for adverse Covid-19 vaccine events and compare that with VAERS and the CDC’s recent conclusion to realize there is a massive cover-up in our government’s efforts to sanitize the safety record of Covid vaccines. As of this week the EudraVigilance system is reporting over 1.5 million injuries and 15,472 deaths. Within those figures, 28,583 injuries and 1,862 deaths are from cardiac complications such as myocarditis.
Second, the EU and US have administered approximately the same number of Covid vaccine doses, roughly 409 million and 379 million respectively. Therefore we should expect to find a similar dose-to-injury ratio. Again we discover the CDC gaming the nation’s reporting system to lessen the perception of lethal risks. Based upon the EU ratio we can conservatively estimate that a minimum of 14,300 Americans have been killed by the vaccines so far. If we go back a week before the CDC scrubbed entries in VAERS, it would be over 17,000 Covid vaccine deaths. The actual number of Americans suffering adverse reactions would be 1.4 million.
In other words the EU is reporting 4 times more vaccine injuries and deaths than American health officials. In both the US and EU, Pfizer’s mRNA vaccine accounts for the majority of these casualties. Unless the Covid-19 vaccines engineer a personal vendetta against people holding EU passports, these numbers don’t add up.
Before the arrival of the Covid vaccines, Merck’s anti-inflammatory drug Vioxx was widely regarded as the single largest pharmaceutical catastrophe in American medical history. The drug should never have been approved and licensed in the first place; and, Merck knew beforehand that the drug would be lethal and concealed that documentation from FDA regulators. Vioxx was on the market for five years before being withdrawn. At the time of the federal class action lawsuit against Merck, FDA epidemiologist Dr. David Graham estimated the drug had killed 60,000 patients due to heart attacks and strokes. Since the majority of deaths were among elderly patients, a later report by the American Conservative predicted that upwards to half a million patients may have died from the drug over the course of a longer period. Yet during those years Merck was cashing in $2 billion annually from Vioxx sales, earning over double its eventual $4.8 billion fine after being found guilty.
To put this into a broader perspective, the Covid vaccines have only been distributed for six months and have now contributed to a realistic 17,000 deaths or upwards towards 30,000 this year alone. Since the vaccines’ immunity quickly wanes and it seems certain they provide little protection against new SARS-2 strains, health officials are already recommending regular booster shots. Similar to a prescription medication, those who buy into the vaccine propaganda hype are in principle relying upon these vaccines for life or until such time the virus resides into just a seasonal nuisance. Consequently iatrogenic vaccine injuries and deaths may likely continue at current rates during forthcoming years. The Covid-19 vaccines are on track to outpace the conservative number of Vioxx deaths over three-fold and even modern medicine’s most deadly drugCerivastatin, manufactured by Bayer in the late 1990s and responsible for over 100,000 deaths during the four-year period it was on the market. In short time, Covid vaccines will be the deadliest drug to have emerged from Big Pharma.
A study published in the Journal of Patient Safety estimated that 400,000 unnecessary and preventable deaths occur annually in American hospitals alone. At that rate, it is not surprising that the large majority of deaths ruled as SARS-2 infections happened in hospitals. If our federal health officials had been competent, and less compromised by the demands and influence of drug makers, most of these fatalities likely would never have occurred.
It has been estimated that US taxpayers have paid out $39 billion for Covid-19 vaccine development, funding and towards nationalized response measures. Most of this has been horribly wasted after we consider other options on hand to curb the pandemic but were categorically ignored. “In the case of vaccines in general,” the journal Health Affairs observed,
“the government often plays an outsized role, but in the era of Covid-19 the government’s role was even more central than usual. The government essentially removed the bulk of traditional industry risks related to vaccine development: a) scientific failures, b) failures to demonstrate safety and efficacy, c) manufacturing risks, and d) market risks related to low demand.”
While this may shock and disturb a rational person, Health Affairs – a thoroughly orthodox medical publication – applauds the government’s negligent measures as “money well spent.”
For this reason it is crucial to understand the terrible decisions made during the Covid pandemic in the context of modern medicine’s past crimes and preventable failures. In the coming months Anthony Fauci’s reputation will become further tainted. We might predict he will resign as more evidence of incompetence emerges, and, in our opinion, perhaps criminal negligence in his handling of the pandemic and efforts to whitewash the US’s role in supporting gain of function research leading to the genetic engineering of the SARS-2 virus. Fortunately, unlike past scandals when misguided medical decisions were responsible for thousands of unnecessary disabilities and deaths, numerous doctors and scientists worldwide are raising their voices to condemn the lethal policies of the CDC, NIAID, British Health Ministry and the World Health Organization.
So what can we reasonably surmise at this point? At one time most Americans trusted science, medicine and our healthcare system without question or criticism. However, today we observe systemic corruption and gross conflicts of interest across the same federal health agencies that have also contributed to untold medical errors and deaths prior to SARS-2 arrival. They have weaponized pharmaceutical science and a supplicant braying media supports this perversion of medical facts. Now the drug-happy media is attacking the truth-tellers, the physicians, professors and accomplished journalists who are risking their careers and reputations to bring forth the fallacies in the pandemic narrative. This is one battle that the silent majority can find its voice and courage to step forth and support.
Richard Gale and Gary Null PhD direct Progressive Radio Network.
Change in the Middle East?
New Israeli government controls the agenda
BY PHILIP GIRALDI • UNZ REVIEW • JUNE 22, 2021
The media focus on the Summit meeting between Presidents Joe Biden and Vladimir Putin has to a certain extent crowded out news about the new government in Israel, headed by hardline nationalist Naftali Bennett. In those media outlets that are actually discussing the change there is an odd sort of perception that Israel’s new government will have to adjust to the new regime in Washington. That would imply that the Israelis will have to mitigate some of their more outrageous behavior to accommodate themselves to Biden’s intention to take actions that will be disapproved of in Jerusalem, to include a possible rapprochement with Iran over its nuclear program and a White House reengagement with the Joint Comprehensive Plan of Action (JCPOA) of 2015.
The New York Times has an interesting article written by its Washington bureau diplomatic correspondent Michael Crowley with contributions from its new correspondent in Jerusalem Patrick Kingsley. The article is entitled “Shift in Israel Provides Biden a Chance for Better Ties” with a sub-heading that reads “The departure of Benjamin Netanyahu as prime minister is a relief for Democrats, but Iran and the Palestinians could test Mr. Biden’s relations with a fragile new Israeli government.”
The article argues that the fact that Biden did not call Netanyahu for three months after his own inauguration but called Bennett within three hours is significant. In the phone call Bennett reportedly blamed Netanyahu for “poisoning” the relationship with the United States, which should surprise no one as that was one of the issues hammered at repeatedly by Bennett during his own electoral campaign.
But one has to look beyond that and ask where is the evidence that Netanyahu’s admittedly acidic personality and arrogance led to any retribution by the White House, either under Barack Obama, Donald Trump or Joe Biden? It was generally reported and probably quite correct that Obama deeply disliked Netanyahu, even once being caught on an open mike speaking to French President Nicolas Sarkozy and regretting the fact that he had to interact with the petulant Israeli Prime Minister every week. Yet Obama then turned around and did something that no American President had ever done, arranging to give the Israeli’s a guaranteed $38 billion in military assistance over the course of ten years. The money was not conditional on Israeli behavior, did not reflect actual US interests, and was then sweetened by another half billion per year to support the Jewish state’s Iron Dome air defense system.
In 2015 the Obama Administration did indeed enter into the JCPOA, a multilateral agreement to monitor and limit Iran’s existing nuclear program, a move that was strongly opposed by Israel, but the only time the White House actually demonstrated any annoyance with Israel was when it abstained on a United Nations vote critical of the Jewish state’s settlements shortly before Obama left office. And it should be observed that Obama was duly punished by Israel for his bad attitude, with Netanyahu showing up at a joint session of Congress to denounce the impending Iran pact in March 2015. Bibi received twenty-nine standing ovations from a completely brainwashed gathering of the “peoples’ representatives.”
And then there is Donald Trump, who was probably the most pro-Israeli president in US history. Trump promoted Israeli interests repeatedly, moving the US Embassy to Jerusalem, recognizing the annexation of the Syrian Golan Heights, de facto approving eventual incorporation of the Palestinian West Bank into Israel, and assassinating a senior Iranian general while also turning a blind eye to illegal settlement expansion and bombing attacks on both Syria and Lebanon. The US also repeatedly used its United Nations veto to prevent any criticism of Israel and its policies. Trump’s Ambassador to Israel David Friedman was notorious for his pander to Israeli interests, approving harsh measures against Palestinians and war crimes directed against its neighbors, so much so that he was perceived as a spokesman-apologist for Israel rather than the US.
Not much “poison” in the relationship as reflected by facts on the ground, is there? The money kept flowing, the political support hardly wavered, and the United States government at all levels could hardly stop gushing about how the Jewish state was a “democracy” and a “close ally,” both of which assertions were and are not true.
So now we come to Biden and talk about a reset. The Times oddly concedes that “The change in government in Israel will hardly wipe away deep differences with the Biden administration: The right-wing Mr. Bennett is ideologically closer to Mr. Netanyahu than to Mr. Biden. And it did not make the longstanding issues in the Middle East any less intractable. But the early interactions suggest a shift in tone and an opportunity, analysts said, to establish a less contentious relationship, with potential implications for dealing with Iran, the Palestinians and the wider region.”
Excuse me, but Bennett ran on a very hard line. He opposes any nuclear agreement with Iran and will not permit anything like a Palestinian state. He has been in office only a short time and has already approved airstrikes against targets in Syria and Gaza as well as a march by thousands of settlers through Palestinian East Jerusalem calling for “Death to Arabs.” A change in tone might be welcome, but as the United States already supinely agrees to support everything claimed by Israel, what will it mean on the ground? Nothing. And the “contentious relationship” is likewise hard to find. The thunder heard along the Potomac several weeks ago consisted of Congress and the White House’s synchronized chanting of “Israel has a right to defend itself!” And then there is the Iranian nuclear deal, which seems to be slipping away as Secretary of State Tony Blinken seemingly adds “conditions” to US reentry. So what are, in reality, the deep differences between Jerusalem and Washington that will be more manageable with “better tone?”
The Times argues perhaps more credibly that the damage has been done re the Israeli government relationship with the Democratic Party itself. It says “Mr. Biden has long considered Mr. Netanyahu a friend, albeit one with whom he often disagrees. But many administration officials and Congressional Democrats viscerally disdain the ousted Israeli leader, whom they came to see as a corrosive force and a de facto political ally of Republicans, including former President Donald J. Trump.”
Excuse me yet again, but such thinking is pie in the sky. To be sure a handful of Democratic Party progressives have come down hard on Israel’s recent slaughter of Gazans, but those who have any real power in the party have not voiced a single criticism of the war crimes committed. Biden might have been able to intervene to shorten the conflict, but he did nothing in reality to put pressure on Israel. His view of the Palestine problem is to give them a state though he is inevitably fuzzy on the details and will put no pressure on the Israelis to take any peace initiatives. In short, he and the Israelis will likely work behind the scenes to reduce the tension so there is no more mass killing and therefore no more negative media. If they are successful, that will make the Palestinians go away.
Joe Biden has called himself a “Zionist” and is proud of it and his first move after Israel was through killing Arabs was to send them $735 million on top of what they already receive from the US taxpayer. And, most important to him is all those Jewish donors whose hands are clutching their checkbooks while their hearts are in Israel, contributing something like two-thirds of all the money going to the Democratic Party. They are led by Hollywood producer Israeli-American Haim Saban who has said unambiguously that he is a “one issue guy and that issue is Israel.” In a sense, Washington is also run by a duopoly that has “one issue” in foreign policy and that issue is also Israel.
Philip M. Giraldi, Ph.D., is Executive Director of the Council for the National Interest, a 501(c)3 tax deductible educational foundation (Federal ID Number #52-1739023) that seeks a more interests-based U.S. foreign policy in the Middle East. Website is https://councilforthenationalinterest.org address is P.O. Box 2157, Purcellville VA 20134 and its email is inform@cnionline.org
The Co-Conspirators have received incredible rewards for their treachery. Let’s start with Rick Bright
By Meryl Nass, MD | June 12, 2021
Rick Bright
Immediately after Rick Bright was transferred out of his position as head of BARDA and sent to the NIH, he started making a huge fuss. The April 22, 2020 NYT discribed his statements:
“While I am prepared to look at all options and to think ‘outside the box’ for effective treatments, I rightly resisted efforts to provide an unproven drug on demand to the American public,” Dr. Bright said. He went on to describe what he said ultimately happened: “I insisted that these drugs be provided only to hospitalized patients with confirmed Covid-19 while under the supervision of a physician.”
By May 14, 2020 Bright was already before Congress, supposedly as the good guy whistleblower who was trying to get things right for the pandemic against huge odds:
Bright told lawmakers Thursday he and other federal health officials had “worked hard” to resist pressure to allow a significant increase in access to hydroxychloroquine, and instead scaled that back to allowing an emergency use authorization but only “with strict guidelines.”
But he said his “concerns were escalated when I learned that officials were pushing to make that drug available outside that emergency authorization.”
“When I spoke outside of the government and shared my concern with the American public, that I believe was the straw that broke the camels back and escalated my removal,” Bright said.
He later said, “The highest priority we have is safety.”
… Bright’s lawyers said last week that the OSC had told them the investigation already had found evidence that Bright was ousted as head of a health agency for pushing back against increasing use of hydroxychloroquine…
HHS, in an emailed statement, said, “Rick Bright was transferred from his role as BARDA director to lead a bold new $1 billion testing program at NIH, critical to saving lives and reopening America.”
“Mr. Bright has not yet shown up for work, but continues to collect his $285,010 salary, while using his taxpayer-funded medical leave to work with partisan attorneys who are politicizing the response to COVID-19,” the statement said.
“His whistleblower complaint is filled with one-sided arguments and misinformation. HHS is reviewing the complaint and strongly disagrees with the allegations and characterizations made by Rick Bright.”
HHS also said that it was under Bright’s leadership that BARDA identified chloroquine and hydroxychloroquine as potential Covid-19 treatments.
“Rick Bright was the sponsor of getting hydroxychloroquine and praised his team for acquiring the drugs,” HHS said.
Bright’s reward? He was made a senior vice president of the Rockefeller Foundation, after refusing to show up for work at NIH. And who raved about him on the Rockefeller Foundation website? None other than Jeremy Farrar and Michael Ryan. I have not written about Ryan so far, but he is another co-conspirator in the efforts to suppress appropriate treatments, poison patients with excess doses of HCQ and prolong the pandemic, as Executive Director of the World Health Organization’s Health Emergencies Programme.
From the Rockefeller Foundation:
“If there is something we have learned throughout the COVID-19 pandemic and other high impact epidemics, it is that pandemic preparedness and response cannot be advanced with a siloed approach,” said Dr. Mike Ryan, Executive Director of the WHO’s Health Emergencies Programme. “Few people bring the full package to the table: profound scientific and public health expertise, years of outbreak response experience, a private and public sector background and a collaborative, innovative, and out-of-the-box mindset. Rick Bright combines all these qualities. His leadership will be an enormous asset to The Rockefeller Foundation and to the global health community.”Dr. Bright resigned from government service in protest over the Trump administration’s approach to handling the Covid-19 pandemic, specifically over the level of political interference in science and the spread of inaccurate information that he said was ‘dangerous, reckless and causing lives to be lost.’
“I’m delighted that Dr. Rick Bright has been appointed as Senior Vice President of Pandemic Prevention and Response at The Rockefeller Foundation,” said Dr. Jeremy Farrar, Director of Wellcome. “The Covid-19 pandemic has highlighted the human and economic costs of epidemics and the fact that we need to be better prepared to identify and respond to emerging infections. Dr. Bright is a leading figure in global health with a wealth of experience, and we look forward to working with him over the coming years.”
Bright’s job at Rockefeller is to work on future pandemic planning. Need I say more?
THIRD member of FDA advisory body resigns, calls Alzheimer’s drug approval ‘worst in recent US history’
RT | June 10, 2021
Three scientists from a FDA advisory committee have resigned after the US food and drug regulator rammed through the approval of a controversial drug to treat Alzheimer’s disease in the face of near-unanimous opposition.
Ten out of 11 members of the Peripheral and Central Nervous System Advisory Committee voted against approving the drug aducanumab, with one voting “uncertain,” during the hearings in November 2020. On Monday, the FDA granted it accelerated approval anyway.
“This week, the aducanumab decision by FDA administrators was probably the worst drug approval decision in recent US history,” wrote Aaron Kesselheim of Harvard and the Brigham and Women’s Hospital in Boston, Massachusetts – who became the third member of the committee to resign in protest this week.
The agency switched to accelerated approval “at the last minute,” based on the “debatable premise” that the drug’s effect was likely to help patients, but “this pivotal question was not discussed at the Advisory Committee meeting, and its premise was specifically excluded from discussion,” Kesselheim wrote. Furthermore, some of the questions asked of the committee were “worded in a way that seemed slanted to yield responses that would favor the drug’s approval.”
Kesselheim, who has served on the committee since 2015, said it was “clear to me that FDA is not presently capable of adequately integrating the Committee’s scientific recommendations into its approval decisions.”
Two neurologists serving on the committee – David Knopman of the Mayo Clinic in Minnesota and Joel Perlmutter of Washington University in St. Louis, Missouri – resigned on Wednesday.
Developed by the Cambridge, Massachusetts-based Biogen and Japan’s Eisai, aducanumab – also known by the trade name Aduhelm – was touted as the first treatment that directly targets the cause of Alzheimer’s disease, instead of merely helping to ease its symptoms. Biogen’s stock surged at the news that the intravenous treatment – the cost of which is estimated at $56,000 a year – had been greenlit by regulators.
Aduhelm is a monoclonal antibody designed to remove a substance called amyloid from the brain of Alzheimer’s patients. Doctors are not in agreement whether this is the cause or the symptom of the disease that presently afflicts an estimated six million Americans. Clinical trials were halted in 2019 after the drug was not shown to be effective, but Biogen “re-analyzed” the data and told the FDA that some patients who received higher doses had shown a slower rate of decline than others.
The FDA then argued that the drug “is reasonably likely to predict a clinical benefit to patients,” even if it did not show clear clinical benefits in slowing down the progression of Alzheimer’s.
Aduhelm was the final straw for Kesselheim, whose letter also cited an earlier incident with the drug called eteplirsen, approved in 2016 for treatment of Duchenne muscular dystrophy against the advisory recommendations.
“For both eteplirsen and aducanumab, the decisions by FDA administrators to ignore the Advisory Committee’s clear recommendations led to their approval of two highly problematic drugs that offered little evidence that they would meaningfully benefit patients suffering from these devastating conditions,” he wrote, adding that the dual debacles “demonstrate that the agency needs to reassess its decision-making processes.”
WHO’s Chief Scientist Served with Legal Notice for Disinformation and Suppression of Evidence
By Colin Todhunter | OffGuardian | June 9, 2021
On 25 May 2021, the Indian Bar Association (IBA) served a 51-page legal notice on Dr Soumya Swaminathan, the Chief Scientist at the World Health Organisation (WHO), for:
[H]er act of spreading disinformation and misguiding the people of India, in order to fulfil her agenda.”
The Mumbai-based IBA is an association of lawyers who strive to bring transparency and accountability to the Indian justice system. It is actively involved in the dissemination of legal knowledge and provides guidance and support to advocates and ordinary people in their fight for justice.
The legal notice says Dr Swaminathan has been:
Running a disinformation campaign against Ivermectin by deliberate suppression of effectiveness of drug Ivermectin as prophylaxis and for treatment of COVID-19, despite the existence of large amounts of clinical data compiled and presented by esteemed, highly qualified, experienced medical doctors and scientists,”
And:
Issuing statements in social media and mainstream media, thereby influencing the public against the use of Ivermectin and attacking the credibility of acclaimed bodies/institutes like ICMR and AIIMS, Delhi, which have included ‘Ivermectin’ in the ‘National Guidelines for COVID-19 management’.”
The IBA states that legal action is being taken against Dr Swaminathan in order to stop her from causing further damage to the lives of citizens of India.

Dr Soumya Swaminathan, WHO Chief Scientist
The notice is based on the research and clinical trials carried out by the ‘Front Line COVID-19 Critical Care Alliance’ (FLCCC) and the British Ivermectin Recommendation Development (BIRD) Panel. These organisations have presented an enormous amount of data that strengthen the case for recommending Ivermectin for the prevention and treatment of COVID-19.
The IBA says that Dr Swaminathan has ignored these studies and reports and has deliberately suppressed the data regarding the effectiveness of Ivermectin, with an intent to dissuade the people of India from using it.
However, two key medical bodies, the Indian Council for Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) Delhi, have refused to accept her stand and have retained the recommendation for Ivermectin, under a ‘May Do’ category, for patients with mild symptoms and those in home isolation, as stated in ‘The National Guidelines for COVID-19 management’.
It is interesting to note that the content of several web links to news articles and reports included in the notice served upon Dr Swaminathan, which was visible before issuing the notice, has either been removed or deleted.
It seems that the vaccine manufacturers and many governments are desperate to protect their pro-vaccine agenda and will attempt to censor information and news regarding the efficacy of Ivermectin.
The legal notice can be read in full on the website of the India Bar Association.
Is there a Problem with the Lopez-Medina, Colombia-based Study Implicating Ivermectin?
Major Pharma Companies Including Merck Funding the Trial Site during the Study
By Michael B. Goodkin MD, FACC | TrialSite News | June 9, 2021
Although a great majority of ivermectin-based studies have indicated real promise, one particular study conducted by a small trial site in Colombia received unprecedented media attention when the study results indicated negligible impact. What hasn’t been disclosed by media is the seriously questionable pharmaceutical industry support of this one trial site. During the study, a handful of some of the largest drug companies in the world gave this site money. What’s not clear is why this occurred and whether the funds are correlated to some nefarious agenda. This author suggests that the publisher should have scrutinized this industry funding perhaps more carefully.
On March 4th, 2021, an article appeared in JAMA titled, “Effect of Ivermectin On Time To Resolution of Symptoms Among Adults With Mild COVID.” It concluded, “The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes.”
Dr. Eduardo Lopez-Medina et al. from Cali, Colombia, randomized 400 mildly ill patients, averaging 37 years old, to ivermectin 0.3 mg/kg or placebo. The time to resolution for ivermectin-treated patients was 10 days and placebo patients 12 days, which was not statistically significant.
Much has been written about the methodologic problems of the study but few read to the bottom of the article to see this:
Conflict of Interest Disclosures: Dr. López-Medina reported receiving grants from Sanofi Pasteur, GlaxoSmithKline, and Janssen as well as personal fees from Sanofi Pasteur during the conduct of the study. Dr. Oñate reported receiving grants from Janssen and personal fees from Merck Sharp & Dohme and Gilead outside the submitted work. Dr. Torres reported receiving nonfinancial support from Tecnoquímicas unrelated to this project during the conduct of the study. No other disclosures were reported.
Considerable press outlets noted this study, we suspect due to the fact that the ivermectin results were negligible, but none of the media addressed the possibility of conflict with industry.
Absolutely nothing has been written about the fact that the study was sponsored by Centro de Estudios en Infectogía Pediatrica and the authors were paid by 3 drug companies making COVID vaccines–Sanofi Pasteur, GlaxoSmithKline, and Janssen– and two making COVID therapeutics–Gilead and Merck.
We have some questions about this. Why did the authors disclose that they were receiving industry sponsor funds during the conduct of the study? Were these funds to actually direct the ivermectin study? That would most certainly be a conflict of interest material.
Merck’s expressed their intent on competing against the ivermectin generic approach. Why would this company be funding this small trial site operation in Colombia?
How could JAMA even think about publishing an article sponsored by 5 drug companies centering on a study targeting a generic competitor? Any layperson seeing this could think that this was highly suspect.
The potential conflict of interest was so severe that no journal should have published it.
Why would anyone do this study?
Was there a pressing need to know if 37-year-old patients got better sooner with ivermectin than placebo? There were a lot of resources put into this study. The only possible reason to do the study was for drug companies to have a vehicle to publish negative data about ivermectin. Is there anyone who believes the study was sponsored to add to the scientific knowledge about ivermectin for the treatment of COVID?
On February 4th, 2021, Merck, who had the original patent on ivermectin, put out a statement regarding ivermectin for COVID:
• No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;
• No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease; and
• A concerning lack of safety data in the majority of studies.
If Merck believed these statements to be true, why would they feel the need to go public with them?
Merck’s vaccine had failed. Merck had bought a company, Oncoimmune, for $425 million and gotten $356 million from HHS in taxpayer money to develop a therapeutic agent, CD24c. They had a material conflict of interest. Later, the European Medicines Agency and World Health Organization both quoted Merck’s statement while ignoring the conflict of interest and science in recommending against the use of ivermectin for COVID, other than for research. Were they influenced by Merck? CD24c was dropped, and Merck has oral antiviral molnupiravir in a phase II-III trial. Why would Merck sponsor a trial of ivermectin?
Why would JAMA publish an article showing that young patients who are expected to recover quickly don’t get better much more quickly with ivermectin?
This article did not warrant publication in JAMA. The only possible reason to publish it was to present false, negative information about ivermectin to readers.
Why was the age of the patients not mentioned in the key findings or conclusions?
The age of the patients made the article irrelevant. It could not have been an accident that the age was not mentioned in the key findings and conclusions. That would never happen at JAMA. The authors anticipated that many readers would miss the age of the patients and conclude that ivermectin is ineffective in early COVID. Dr. Adfarsh Bhimraj at Cleveland Clinic who heads the committee writing COVID recommendations for the Infectious Disease Association of America spoke with Helio Medical News on ivermectin. He had a similar observation in the Washington Post.
“This was a well-done, but small trial in patients with mild or moderate disease,” Bhimraj said. He suggested that this is a negative study for a non-mortality outcome, but because the numbers were small, it might not have produced a statistically significant difference in effect size. The evidence is not enough to warrant a recommendation for the use of ivermectin. Other US experts who commented on the article have failed to notice the age of the patients and drug company sponsorship. It has crossed few American physicians’ minds that JAMA could be corrupted and knowingly publish a study with deceptive results in order to help drug companies.
Was the data fraudulent?
If the purpose of the article was to make it appear that ivermectin was ineffective in mild COVID, there is no reason to believe the data was real. There is no published randomized data for comparison. In the Dominican Republic, Dr. Jose Natalio Redondo reported that in 1300 patients with all degrees of illness, the length of illness went from 21 days to 10 days with ivermectin treatment.
Was JAMA aware that there was concern they had been corrupted and the article unreliable?
Sixteen members of the AMA Board of Directors were emailed that it appeared that JAMA had been infiltrated and the article fraudulent on March 10th, 2021. Eleven JAMA editorial board members were emailed about it April 12th. And one was spoken to. The same email was sent to executive editor Dr. Phil Fontanarosa April 13th. This reply was sent:
“Your message was brought to my attention.
I will look into these issues as outlined in your letter.
Please bear with me, as this will take some time, given the number of issues and the complexity of the concerns you raise, as well as other urgent issues and priorities we are addressing right now.”
As of 6/8/21, the article has been read online 759,000 times. How many of those readers concluded that ivermectin is ineffective for mild COVID and, as a result, did not prescribe it for their patients? To put things in perspective, Uttar Pradesh, India, with 210 million people, started ivermectin in August. By December, their mortality rate was 0.26 per 100,000. In the US, in December, it was 11 times higher at 2.8 per 100,000. Admissions in Mexico are down 75% due to ivermectin.
The JAMA article of 3/4/21 was a cleverly devised drug company creation designed to create the false impression that ivermectin was ineffective in mild COVID by claiming it didn’t shorten the duration of illness significantly. They knew people would miss the age of the patients and not read to the bottom of the article to see that it was sponsored by 5 drug company competitors. They knew people would leap to the conclusion that ivermectin was completely ineffective for COVID, not realizing that the article could not address its effects on hospitalization and death. An infectious disease doctor friend sent it to me as proof that ivermectin does not work. Drug companies would not have gone to these lengths if they did not fear ivermectin as a competitor.
JAMA reviewers could not possibly have missed the obvious conflict of interest. It was obviously their intention to spread misinformation. Leaving out the age of the patients was intentional to make readers think it was ineffective in everyone. The article has not only led to patient care being adversely affected but the article has been widely quoted as evidence against the use of ivermectin. WHO says it is the number one article in support of its position.
Doctors should contact JAMA to understand what is going on with the investigation. JAMA should report on their findings as they committed to this author to undertake an investigation.
